期刊文献+

闭合型双循环生物人工肝支持系统的构建 被引量:1

Construction of closed bi-circulating bioartificial liver support system (CBC-BALSS)
下载PDF
导出
摘要 目的 构建简便、安全和稳定的闭合型双循环生物人工肝支持系统 (closedbi -circulat ingbioartificialliversupportsystem ,CBC -BALSS)。方法 采用改良两步原位胶原酶灌注法分离猪肝细胞。利用肝细胞、细胞池和BiolivA3A生物反应器构建CBC -BALSS ,进行 8次闭合循环实验 ,监测双循环路压力 ,肝细胞密度和活率、生化全套和MEGX。结果 闭合循环过程中 ,双循环路压力于 30min后趋于平稳至 (10 5± 5 )mmHg。循环中肝细胞总数、活率和密度变化无显著性差异。细胞循环路ALT、LDH、TB、DB和ALB在各时间点间均不存在显著性差异 ;TB和DB显著性升高。结论 在闭合循环实验中 ,肝细胞活率和功能良好 ,双循环路压力平稳 ,生物膜通透性好。我们构建的CBC -BALSS安全、稳定、有效 。 Objective To construct stable, safe and efficacious CBC-BALSS. Methods Suckling swine hepatocytes were isolated by modified two-setp in situ collagenase perfusion method and cultured in serum-free medium at high density. CBC-BALSS was constructed with hepatocytes, cell kettle and Bioliv A3A bioreator. The hepatocytes in closed tube were circulated 8 times in this study. During every circulation, bi-circulating pressure were observed, while cell viability, density, biochemistrical index and MEGX were also evaluated. Results During circulation, bi-circulating pressure was elevated to 105 mmHg gradually with fluctuating around ±5 mmHg. The cell number, viability, density, ALT, TB, DB, ALT and LDH were stable in whole circulation. Change of MEGX in circulating hepatocytes were similar to those in stirring culture ones. There are no significant difference in ALT, LDH and ALB in RPMI1640 circulation at each time point, but TB and DB were elevated significantly. Conclusions The viability and function of hepatocytes and pressure in bicirculation is maintained well in closed circulating experiment, so as to the permeability of the membrane in bioreator. CBC-BALSS constructed with Bioliv A3A and cell kettle successfully is stable, safe and efficacious.
出处 《消化外科》 CSCD 2003年第3期163-167,共5页 Journal of Digestive Surgery
基金 20 0 0年江苏省卫生厅重点项目 (BQ2 0 0 0 2 0 )
关键词 闭合型双循环生物人工肝支持系统 两步原位胶原酶灌注法 猪肝细胞 BiolivA3A生物反应器 bi-circulating bioartificial liver hepatocyte/swine construction
  • 相关文献

同被引文献7

  • 1Seglen P O.Preparation of isolated rat liver cells[J].Methods Cell Biol,1976,13:29-83.
  • 2Chapman R W,Forman D,Peto R,et al.Liver transplantation for acute hepatic failure[J]? Lancet,1990,335(8680):32-35.
  • 3Sotaniemi E A,Rautio A,Backstrom M,et al.CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients[J].Br J Clin Pharmacol,1995,39(1):71-76.
  • 4Chen Y,Potter J M.Fluorescence polarization immunoassay and HPLC assays compared for measuring monoethylglycinexylidide in liver-transplant patients[J].Clin Chem,1992,38(12):2426-2430.
  • 5Stange J,Mitzner S R,Risler T,et al.Molecular absorbent recycling system (MARS):clinical results of a new membrane-based blood purification system for bioartificial liver support[J].Artif Organ,1999,23(4):319-330.
  • 6Watanabe F D,Demetriou A A.Support of acute liver patients with a bioartificial liver[J].J Chin Aphercaia,1996,11(3):138-142.
  • 7陈钟,丁义涛,徐庆祥,余德才.犬急性肝衰竭一种新模型的建立[J].中国普通外科杂志,2003,12(3):206-208. 被引量:11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部